目的 探讨品管圈(QCC)在急性缺血性脑卒中(AIS)患者中的应用效果.方法 选取2019年1月至2019年6月我院急诊抢救室收治的30例AIS静脉溶栓患者,设为对照组(采用常规流程治疗),将2019年7月至2019年12月收治的30例AIS静脉溶栓患者设为观察组(成立QCC小组,采用QCC优化流程救治).比较两组的应用效果.结果 观察组的入院至评估患者、入院至获得影像学检查、取药-溶栓、DNT用时均短于对照组(P<0.05).观察组的溶栓有效率和DNT达标率均高于对照组(P<0.05).结论 开展QCC活动可提高AIS患者静脉溶栓DNT达标率,同时提升了医护人员应用QC手法解决临床实际问题的能力.

总结体外膜肺氧合(ECMO)成功救治ARDS病人的临床护理经验,患者经ECMO治疗后成功撤离,病情好转由ICU转入普通病房,使用ECMO治疗的过程中:加强基础护理和机械通气的气道护理及并发症的预防是ECMO救治成功的保证.

目的:探索甲状腺功能减退对更年期高血压患者动态血压的影响.方法:选择2016年5月至2017年5月在本院接受治疗的更年期高血压合并甲状腺功能减退女性患者40例为观察组,无甲状腺功能减退症状的更年期高血压女性患者40例为对照组,对两组患者进行24h动态血压监测.结果:两组患者的24h平均收缩压、白天及夜间平均血压、24h血压负荷、收缩压变异系数无显著差别(P＞0.05).观察组患者24h平均舒张压及舒张压变异系数显著高于对照组(P＜0.05).结论:甲状腺功能减退对更年期高血压患者的舒张压具有一定的影响.

Objective To investigate the effect and the impact of different treatment ,regimens in patients with hypertension and renal injury .Methods 100 cases from April 2012 to April 2014 in our hospital with hypertension and renal injury were randomly divided into A and B 2 groups ,50 cases each .Group A ,the experimental group ,were given sodium tanshinone ⅡA and irbesartan ;Group B as the control group ,only given irbesartan treatment .The course was 28 days .Before and after the treatment ,the systolic and di‐astolic blood pressure ,24 h urinary protein ,urinary immunoglobulin G(IgG) and changes in serum levels of PCX and PICP were observed .Results After a course of treatment ,the systolic blood ,diastolic blood pressure ,24 h urinary protein ,urinary immuno‐globulin (IgG) and serum PCX and PICP levels of group A were signifantly lower than that of group B .Conclusion Sodium tanshi‐non ⅡA silate sodium combined with irbesartan treatment of renal impairment in patients with high blood pressure showed a good effect .The vascular status was improved ,and the kidneys ,protection was better than the effect of irbesartan alone .